Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluoropropane Microbubbles vs SonoVue for CEUS in Focal Liver Lesions
CTR20221728Phase 3Completed
- Sponsor
- Feiruida Medical
- Start
- Oct 2022
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of perflutren lipid microspheres in focal liver lesion, sponsored by Feiruida Medical. Started Oct 2022; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
focal liver lesion
Beyond the preview
Go deeper on CTR20221728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221728.